Latest article
Hepatoselective glucokinase activator exhibits early promise in sort 1 diabetes
medwireNews: Early results suggest that a novel molecule that selectively targets glucokinase...
Lilly Companions with Biopharma Agency on Diabetes Therapies
INDIANAPOLIS (Inside Indiana Business) - Indianapolis-based Eli Lilly and Co. (NYSE: LLY) has signed a research collaboration and licensing agreement with Biolojic Design, an...